Imidazolylalkylcarbonyl derivatives as calcium channel modulators and preparation method thereof
Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.
1. Imidazolylalkylcarbonyl derivatives represented by the formula 1 or their pharmaceutically acceptable salts thereof:
wherein
Y is
n is an integer of from 2 to 4, m is an integer of from 1 to 4;
R 1 and R 2 , being same or different with each other, are respectively a hydrogen atom, C 1 -C 8 alkyl group, substituted or unsubstituted phenyl group, or substituted or unsubstituted benzyl group; and
R 3 is a hydrogen atom, C 1 -C 8 alkyl group, C 1 -C 8 hydroxyalkyl group, CH(substituted or unsubstituted phenyl) 2 , substituted or unsubstituted phenyl group, or substituted or unsubstituted benzyl group;
wherein said substituted phenyl or benzyl is respectively substituted with a substituent selected from the group consisting of halo, hydroxy, carboxy, alkoxycarbonyl, nitro, amino, mercapto, C 1 -C 8 alkyl, and C 1 -C 8 alkoxy groups.
2. The imidazolylalkylcarbonyl derivatives according to claim 1 , wherein
said Y is
said n is an integer of from 2 to 4, m is an integer of from 1 to 4;
said R 1 and R 2 are respectively a hydrogen atom, C 1 -C 8 alkyl group, or substituted or unsubstituted phenyl group; and
said R 3 is a hydrogen atom, C 1 -C 8 alkyl group, C 1 -C 8 hydroxyalkyl group, CH(substituted or unsubstituted phenyl) 2 , substituted or unsubstituted phenyl group, or substituted or unsubstituted benzyl group; and
wherein said substituted phenyl or benzyl is respectively substituted with 1-3 substituents selected from the group consisting of halo, C 1 -C 8 alkyl, C 1 -C 8 alkoxy groups.
3. The imidazolylalkylcarbonyl derivatives according to claim 2 ,
said Y is
m and n respectively represent an integer of 2 or 3;
said R 1 and R 2 respectively are a hydrogen atom, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, or phenyl group;
said R 3 is methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2,3-difluorophenyl, 2,4-difluorophenyl, 3,4-difluorophenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,3-dichlorophenyl, 2,4-dichlorophenyl, 3,4-dichlorophenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2,3-dimethylphenyl, 2,4-dimethylphenyl, 3,4-dimethylphenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 2,3-dimethoxyphenyl, 2,4-dimethoxyphenyl, 3,4-dimethoxyphenyl, benzyl, 2-fluorobenzyl, 3-fluorobenzyl, 4-fluorobenzyl, 2,3-difluorobenzyl, 2,4-difluorobenzyl, 3,4-difluorobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2,3-dichlorobenzyl, 2,4-dichlorobenzyl, 3,4-dichlorobenzyl, 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2,3-dimethylbenzyl, 2,4-dimethylbenzyl, 3,4-dimethylbenzyl, 2-methoxybenzyl, 3-methoxybenzyl, 4-methoxybenzyl, 2,3-dimethoxybenzyl, 2,4-dimethoxybenzyl, 3,4-dimethoxybenzyl, diphenylmethyl, 2-fluorophenyl(phenyl)methyl, 3-fluorophenyl(phenyl)methyl, 4-fluorophenyl(phenyl)methyl, 2,3-difluorophenyl(phenyl)methyl, 2,4-difluorophenyl(phenyl)methyl, 3,4-difluorophenyl(phenyl)methyl, 2-chlorophenyl(phenyl)methyl, 3-chlorophenyl(phenyl)methyl, 4-chlorophenyl(phenyl)methyl, 2,3-dichlorophenyl(phenyl)methyl, 2,4-dichlorophenyl(phenyl)methyl, 3,4-dichlorophenyl(phenyl)methyl, 2-methylphenyl(phenyl)methyl, 3-methylphenyl(phenyl)methyl, 4-methylphenyl(phenyl)methyl, 2,3-dimethylphenyl(phenyl)methyl, 2,4-dimethylphenyl(phenyl)methyl, 3,4-dimethylphenyl(phenyl)methyl, 2-methoxyphenyl(phenyl)methyl, 3-methoxyphenyl(phenyl)methyl, 4-methoxyphenyl(phenyl)methyl, 2,3-dimethoxyphenyl(phenyl)methyl, 2,4-dimethoxyphenyl(phenyl)methyl, 3,4-dimethoxyphenyl(phenyl)methyl, bis(2-fluorophenyl)methyl, bis(3-fluorophenyl)methyl, bis(4-fluorophenyl)methyl, bis(2,3-difluorophenyl)methyl, bis(2,4-difluorophenyl)methyl, bis(3,4-difluorophenyl)methyl, bis(2-chlorophenyl)methyl, bis(3-chlorophenyl)methyl, bis(4-chlorophenyl)methyl, bis(2,3-dichlorophenyl)methyl, bis(2,4-dichlorophenyl)methyl, bis(3,4-dichlorophenyl)methyl, bis(2-methylphenyl)methyl, bis(3-methylphenyl)methyl, bis(4-methylphenyl)methyl, bis(2,3-dimethylphenyl)methyl, bis(2,4-dimethylphenyl)methyl, bis(3,4-dimethylphenyl)methyl, bis(2-methoxyphenyl)methyl, bis(3-methoxyphenyl)methyl, bis(4-methoxyphenyl)methyl, bis(2,3-dimethoxyphenyl)methyl, bis(2,4-dimethoxyphenyl)methyl, or bis(3,4-dimethoxyphenyl)methyl group.
4. The imidazolylalkylcarbonyl derivatives according to claim 1 selected from the group consisting of:
1-N-[2-(4-diphenylmethylpiperazin-1-yl)ethyl]carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(2,3-dimethylphenyl)(phenyl)methylpiperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(3-chlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(3,4-dichlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(3,4-dichlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(3-chlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(2,4-dimethylphenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(2,4-dimethylphenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(4-chlorophenyl)(phenyl)methylpiperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(4-chlorophenyl)(phenyl)methylpiperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(2-fluorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(2-fluorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(3-methylbenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(3-methylbenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(4-fluorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(4-fluorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-[2-(4-phenylpiperazin-1-yl)ethyl]carbamoylethyl-4-phenylimidazole
1-N-[2-(4-phenylpiperazin-1-yl)ethyl]carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(4-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(4-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(4-methoxyphenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(4-methoxyphenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(3-chlorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-phenylimidazole
1-N-{2-[4-(3-chlorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-{2-[4-(2,3-dimethylphenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-phenylimidazole
1-N-[2-(4-diphenylmethylpiperazin-1-yl)ethyl]carbamoylethyl-4-phenylimidazole
1-N-[2-(4-benzylpiperazin-1-yl)ethyl]carbamoylethyl-2-phenylimidazole
1-N-[2-(4-benzylpiperazin-1-yl)ethyl]carbamoylethyl-4-phenylimidazole
1-N-[2-(4-phenylpiperazin-1-yl)ethyl]carbamoylethyl-2-methylimidazole
1-N-[2-(4-phenylpiperazin-1-yl)ethyl]carbamoylethyl-4-methylimidazole
1-N-{2-[4-(4-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-{2-[4-(4-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(4-fluorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(4-fluorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(2-fluorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-{2-[4-(4-chlorophenyl)(phenyl)methylpiperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(4-chlorophenyl)(phenyl)methylpiperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-{2-[4-benzylpiperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-[2-(4-diphenylmethylpiperazin-1-yl)ethyl]carbamoylethyl-2-methylimidazole
1-N-{2-[4-(4-methoxybenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-{2-[4-(4-methoxybenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(3,4-dichlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(3,4-dichlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-{2-[4-(4-chlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(4-chlorobenzyl)piperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole
1-N-{2-[4-(3-chlorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-2-methylimidazole
1-N-{2-[4-(3-chlorophenyl)piperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole and 1-N-{2-[4-diphenylmethylpiperazin-1-yl]ethyl}carbamoylethyl-4-methylimidazole.
5. A pharmaceutical composition comprising imidazolylalkylcarbonyl derivatives or their pharmaceutically acceptable salts according to claim 1 as an active ingredient for the prevention or treatment of diabetes, cerebral diseases, cardiac diseases and pain-associated diseases due to their antagonistic action against T-type calcium channel; diabetes, epilepsy, Parkinson's disease, or dementia; hypertension, cardiac arrhythmia, angina pectoris, myocardial infarction, congestive heart failure; neuropathic pains, chronic pains, or acute pains.